GlycoVaxyn: A new Gain for GSK’s Vaccines Business
GSK, who was already a minority shareholder in GlycoVaxyn, acquires the company and its biological…
GSK, who was already a minority shareholder in GlycoVaxyn, acquires the company and its biological…
The revolutionary Equilia system, meant to treat heart failure, has been successfully implanted for the…
The second edition of the Hello Tomorrow Challenge has been launched in December 2014. This…
AB Science SA, a pharmaceutical company specialized in research, development and marketing of protein kinase…
Producing biologicals in living expression systems is a big challenge for the Biotech industry. World…
Six years after the creation of the company, Fermentalg, an industrial biotechnology company that specializes in…
There is no need to say it: biotechnology is the latest trend. A worldwide bio-boom…
Moderna is the Biotech company that raised the biggest VC round ever ($450M) and which…
New agreement was signed between AYOXXA, an international biotech company with headquarters in Cologne, and…
4D Pharma, a biopharmaceutical company focusing on significant new therapeutic areas, plan to raise €46M…
Gilead Sciences announces the acquisition of Phenex Pharmaceuticals’ development program for non-alcoholic steatohepatitis (NASH) and…
European biotechnology company Valneva and UK company Immune Targeting Systems (ITS) announced that they have…